Instituto de Investigaciones Biomédicas de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

    Biomedicine and Pharmacotherapy, Vol. 162

2020

  1. Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical-Cellular) Screening System

    Advanced Therapeutics, Vol. 3, Núm. 8

  2. Evaluation of biochemical and hematological parameters in adults with Down syndrome

    Scientific Reports, Vol. 10, Núm. 1

  3. Immunization with the Gly1127-Cys1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies

    Theranostics, Vol. 10, Núm. 7, pp. 3263-3280

  4. LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells

    Cells, Vol. 9, Núm. 1

2019

  1. Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1861, Núm. 7, pp. 1302-1316

2018

  1. Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 9, pp. 4197-4208

2017

  1. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs

    Revista Espanola de Cardiologia, Vol. 70, Núm. 9, pp. 763-769